Stratos Wealth Advisors, LLC Abb Vie Inc. Transaction History

Stratos Wealth Advisors, LLC

$1.63 Billion
Q1 2024

A detailed history of Stratos Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 24,599 shares of ABBV stock, worth $4.08 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

24,599

Previous 59,351 58.55%

Holding current value

$4.08 Million

Previous $9.2 Million 51.3%

% of portfolio

0.28%

Previous 0.55%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $5.55 Million - $6.33 Million	-34,752 Reduced 58.55%	24,599 $4.48 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $395,875 - $445,848	-2,877 Reduced 4.62%	59,351 $9.2 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $1.36 Million - $1.58 Million	10,205 Added 19.62%	62,228 $9.28 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $30,079 - $37,432	-227 Reduced 0.43%	52,023 $7.01 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $100,503 - $115,745	-695 Reduced 1.31%	52,250 $8.33 Million

Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $270,119 - $323,944	1,953 Added 3.83%	52,945 $0
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $562,474 - $645,120	-4,191 Reduced 7.59%	50,992 $6.84 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $31,514 - $40,065	229 Added 0.42%	55,183 $8.45 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $448,731 - $556,750	-3,400 Reduced 5.83%	54,954 $8.91 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $79,713 - $100,860	742 Added 1.29%	58,354 $7.9 Million
Q3 2021 Oct 19, 2021	SELL	$106.4 - $120.78 $51,923 - $58,940	-488 Reduced 0.84%	57,612 $6.22 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $278,070 - $309,786	2,643 Added 4.77%	58,100 $6.54 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $354,162 - $389,890	-3,462 Reduced 5.88%	55,457 $6 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $488,171 - $659,083	6,065 Added 11.48%	58,919 $6.31 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $36,597 - $42,953	426 Added 0.81%	52,854 $4.63 Million
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $3.12 Million - $4.17 Million	42,460 Added 425.96%	52,428 $5.15 Million
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $34,120 - $51,730	529 Added 5.6%	9,968 $759,000
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $147,145 - $184,110	-2,040 Reduced 17.77%	9,439 $836,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $14,674 - $17,642	233 Added 2.07%	11,479 $869,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $14,913 - $19,063	227 Added 2.06%	11,246 $818,000
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $2,005 - $2,360	26 Added 0.24%	11,019 $888,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $855,805 - $1.06 Million	10,993 New	10,993 $1.01 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.

Account

Stratos Wealth Advisors, LLC Abb Vie Inc. Transaction History